TICEVIS Tablet Ref.[28258] Active ingredients: Loratadine

Source: Υπουργείο Υγείας (CY)  Revision Year: 2020  Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Product name and form

Ticevis 10mg tablets.

Pharmaceutical Form

Tablet.

White, round, convex tablets.

Qualitative and quantitative composition

Each tablet contains 10 mg loratadine.

Excipient with known effect: lactose monohydrate.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Loratadine

Loratadine is a tricyclic antihistamine with selective, peripheral H1-receptor activity. Loratadine has no clinically significant sedative or anticholinergic properties in the majority of the population and when used at the recommended dosage.

List of Excipients

Lactose monohydrate
Starch maize
Magnesium stearate

Pack sizes and marketing

Tablets are packed into PVC-Al blisters in a carton box with a patient information leaflet.

Boxes of 10, 20 and 30 are available.

Not all pack sizes may be marketed.

Marketing authorization holder

MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus

Marketing authorization dates and numbers

18730

Date of first authorization: 01.03.2000
Date of renewal: 16.01.2013

Drugs

Drug Countries
TICEVIS Cyprus, Hong Kong

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.